What is Known:
Postnatal corticosteroid is a proposed strategy for preventing
Bronchopulmonary Dysplasia (BPD) in preterm neonates. However, it is
known that corticosteroids have potential side effects, demanding a
careful assessment of their risk-benefit profile before administration.
The predictive tools for BPD developed until the moment have limitations
when applied to populations with unique characteristics like preterm
born in developing countries, which could affect their accuracy.